Calypso Biotech
Series ACalypso Biotech raised €20M in a Series A round in Jan 2019. The company is based in Geneva, Netherlands. Investors in the round: Gilde Healthcare, INKEF Capital. Data as of Nov 2026.
Amount raised
€20M
€20,000,000
Native amount
20,000,000 EUR
Stage
Series A
series a
Investors
2
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €20M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
2 namedDate
Jan 2019
Round type
series a
Amount (EUR)
€20M
Other rounds
same companyThis is the company's only recorded round.